SOURCE: NanoVibronix, Inc.

NanoVibronix, Inc.

February 25, 2016 13:18 ET

NanoVibronix Announces Favorable Response to Presentation at the American Academy of Pain Medicine 32nd Annual Meeting at the Palms Springs Convention Center in California

ELMSFORD, NY--(Marketwired - February 25, 2016) - NanoVibronix, Inc, (OTCQB: NAOV), developer of the patented low intensity surface acoustic wave technology for pain management, wound healing and other indications, today announced that its PainShield®, for chronic and acute pain and sports injuries, was well received at the American Academy of Pain Medicine (AAPM) 32nd annual meeting at the Palms Springs Convention Center in Palm Springs, CA. The AAPM Annual Meeting is considered one of the most creative and informative meetings in the industry. With nearly 1,000 attendees, AAPM's Annual Meeting is a premiere pain conference for primary care physicians, pain specialists, and members of the pain treatment team.

William Stern, PhD Chief Executive Officer of NanoVibronix, stated, "We are extremely pleased with the overwhelmingly positive response to our PainShield® device, at the annual meeting of the American Academy of Pain Medicine. PainShield® utilizes our patented, wearable ultrasound platform, and is the first wearable hands-free, patch-based device that delivers localized surface acoustic wave energy, creating a therapeutic effect to relieve localized pain and induce soft tissue healing. PainShield® is intended for chronic and acute pain and is highly applicable to sports injuries such as ankle pain, tendonitis, knee pain, shoulder pain, muscle pain, as well as injuries to other areas of the body, including pelvic pain. Using our advanced low cost technology we can now bring therapeutic benefit to patients in their own homes. The hands-free feature allows patients access to technology that was never before available outside of a clinical setting. Treatment for pain with the PainShield® is also a more permanent solution than the office ultrasound treatments which usually last only during the application in the office or, for at most, a short time afterward. PainShield® enables athletes to get back in the game sooner than with other treatment modalities."

About NanoVibronix 
NanoVibronix Inc. is a medical device company headquartered in Elmsford, NY with research and development in Nesher, Israel, that is focused on developing medical devices utilizing its proprietary and patented low intensity surface acoustic wave technology. The company's groundbreaking technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications. The devices accelerate wound healing and provide pain relief. The devices can also be administered at home, without the assistance of medical professionals. The company's patch based products include the PainShield® and the WoundShield™ which are CE Marked. The PainShield™ also has FDA clearance. NanoVibronix's catheter based products include the UroShield™ and NG-Shield™ that are both CE Marked. Additional information about the company is available at: www.nanovibronix.com.

SAFE HARBOR STATEMENT: This release contains certain statements that are, or may be deemed to be, forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and section 21E of the Securities Exchange Act of 1934, and are made in reliance upon the protections provided by such Acts for forward-looking statements. We have identified forward-looking statements by using words such as "expect," "believe," and "should." Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form SEC filings.

Contact Information

  • Investor Relations Contacts:
    Rodd Leeds or Natalya Rudman
    Crescendo Communications, LLC
    Email: naov@crescendo-ir.com
    Tel: 212-671-1020